Thermo Fisher Sci…
USUSDThermo Fisher Scientific Inc (US:TMO) — Industrial Machinery/Components. Biržu skaits, kurās tiek tirgotas uzņēmuma akcijas: 3. Šajā lapā — cena un grafiks, dividendes, lielākie akcionāri un akciju skaita vēsture.
Par uzņēmumu
- Tīmekļvietne
- thermofisher.com
- Nozare
- Industrials · Industrial Machinery/Components
- Galvenā mītne
- Waltham, United States
- Izpilddirektors
- Mr. Marc N. Casper
- Darbinieki
- 67 816
- Dibināts
- 2006
- Apgrozībā esošās akcijas
- 369.75 milj. uz 2026-06-27
- Brīvā apgrozība
- 368.82 milj.
- Tirgus kapitalizācija
- 241.26 mljrd. USD
- Iekšējās personas
- 0.13%
- Institucionālie investori
- 94.08%
- Nozare (SIC)
- Measuring & Controlling Devices, NEC
- Juridiskā forma
- XTIQ
- ISIN
- US8835561023
- LEI
- HCHV7422L5HDJZCRFL38
- Izmaksas koeficients
- 9.5%
- FCF
- 7.32 mljrd. USD9%
- Parāds
- 42.5 mljrd. USD5.3 g. FCF
- Dividenžu stāžs
- 14 g.
- Peļņa, FCF un izmaksātās dividendes — par 12 mēnešiem līdz 30.06.2026 (uzņēmuma jaunākais ziņojums).
Apraksts
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Dividendes
Thermo Fisher Scientific Inc (TMO) izmaksā dividendes reizi ceturksnī. Pēdējo 12 mēnešu laikā tika samaksāts 1.84 USD par akciju (maksājumi: 4). Tas ir aptuveni 0.28% no pašreizējās akciju cenas. Pamatojoties uz maksājumu vēsturi, nākamais ex-dividendes datums tiek gaidīts ap 15.12.2026. Nepārtrauktu dividenžu gadi: 14.
| Ex-datums | Izmaksa | Summa | % | Veids | Tikeris |
|---|---|---|---|---|---|
| 2026-09-15 | 2026-10-15 | 0.4700 USD | 0.1/0.3 % | ceturkšņa | US:TMO |
| 2026-06-15 | 2026-07-15 | 0.4700 USD | 0.1/0.3 % | ceturkšņa | US:TMO |
| 2026-03-13 | 2026-04-15 | 0.4700 USD | 0.1/0.3 % | ceturkšņa | US:TMO |
| 2025-12-15 | 2026-01-15 | 0.4300 USD | 0.1/0.3 % | ceturkšņa | US:TMO |
| 2025-09-15 | 2025-10-15 | 0.4300 USD | 0.1/≈0.3 % | ceturkšņa | US:TMO |
| 2025-06-13 | 2025-07-15 | 0.4300 USD | 0.1/≈0.3 % | ceturkšņa | US:TMO |
| 2025-03-14 | 2025-04-15 | 0.4300 USD | 0.1/≈0.3 % | ceturkšņa | US:TMO |
Ziņas šonedēļ
Pēdējās nedēļas laikā nav ziņu. Jaunākās ziņas: 28.09.2026.
Lielākie akcionāri
| Turētājs | Daļa | Akcijas | Pārskata datums |
|---|---|---|---|
| Blackrock Inc. | 8.36% | 30.92 milj. | 2026-06-30 |
| Vanguard Capital Managem… | 6.57% | 24.28 milj. | 2026-06-30 |
| State Street Corporation | 4.55% | 16.83 milj. | 2026-06-30 |
| FMR, LLC | 3.81% | 14.08 milj. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.19% | 11.8 milj. | 2026-06-30 |
| Morgan Stanley | 2.91% | 10.76 milj. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.6% | 9.63 milj. | 2026-06-30 |
| JPMORGAN CHASE & CO | 2.3% | 8.5 milj. | 2026-06-30 |
| Geode Capital Management… | 2.27% | 8.38 milj. | 2026-06-30 |
| Franklin Resources, Inc. | 1.97% | 7.27 milj. | 2026-06-30 |
| Vanguard Portfolio Manag… | 1.68% | 6.23 milj. | 2026-06-30 |
| Capital World Investors | 1.68% | 6.2 milj. | 2026-06-30 |
| iShares Trust-iShares Co… | 1.34% | 4.95 milj. | 2026-08-31 |
| Fidelity Concord Street… | 1.3% | 4.81 milj. | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.23% | 4.55 milj. | 2026-08-31 |
| Fidelity Contrafund | 1.06% | 3.91 milj. | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 0.96% | 3.54 milj. | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 2.67 milj. | 2026-08-31 |
| Dodge & Cox Funds-Dodge… | 0.56% | 2.06 milj. | 2026-06-30 |
| VANGUARD INSTITUTIONAL I… | 0.55% | 2.02 milj. | 2026-06-30 |
| CASPER MARC N (Chief Exe… | ≈0.04% | 140 225 | 2026-08-24 |
| LAGARDE MICHEL (Chief Op… | ≈0.02% | 86 347 | 2026-02-25 |
| SPERLING SCOTT M (Direct… | ≈0.02% | 69 479 | 2026-05-20 |
| WILLIAMSON STEPHEN (Chie… | ≈0.01% | 46 095 | 2026-02-25 |
| PETTITI GIANLUCA (Presid… | ≈0.01% | 23 216 | 2026-08-31 |
| SHAFER MICHAEL D (Office… | ≈0.01% | 20 994 | 2026-08-11 |
| LOWERY FREDERICK M. (Off… | ≈0% | 17 133 | 2026-02-25 |
| CHAI NELSON J (Director) | ≈0% | 15 316 | 2026-05-20 |
| BRITT LISA P (Officer) | ≈0% | 14 784 | 2026-08-19 |
| BOXER MICHAEL A (General… | ≈0% | 10 815 | 2025-03-10 |
